Company details

Medibio Limited

  • Print
  • Share Share
en

Medibio Limited (ASX:MEB) is an Australian listed company developing a Digital Mental Health Platform. Medibio’s patented biomarker is based on the circadian heart rate architecture and has been developed over 15 years of research involving more than 5000 patients. The company is currently conducting trials to support FDA approvals.